Closing Bell: Arch Biopartners Inc down on Monday (ARCH)

Today in trading, Arch Biopartners Inc opened at $1.59 and closed at $1.50. It traded at a low of $1.49 to a high of $1.59.

Shares decreased -4.46% from the previous day's close of $1.57.

Today across North America, the TSX Composite closed 0.80% at 22872.65, the S&P 500 closed -0.71% at 5505.00, the Dow Jones Industrial Average closed -0.93% at 40287.53 and the Nasdaq Composite closed -0.81% at 17726.94.

Arch Biopartners Inc has listed on the Toronto Venture Exchange (TSX-V) under the ticker ARCH.

Trading volume was 13,940 on 34 total trades, while having an average volume of 19,531 over 5 days.

The TSX-V overall saw 3,734 price advancers against 1,480 declines and 101 unchanged.

During the prior 52 weeks, ARCH.VN has traded as high as $2.56 (March 18,2024) and low as $0.97 (November 03,2023). Moreover, the shares have shrunken -29.25% in the last 12 months, while they have advanced 1.35% this year.

It announced a 0.05 dividend on January 01/70, with an December 05/89 ex-date and January 01/70 pay day.

Following today's trading, Arch Biopartners Inc has a market capitalization of $100.25 million on a float of 63,851 shares outstanding. Its annual EPS is $-0.03.

Arch Biopartners Inc is a TSX Biotechnology company headquartered in Toronto, CAN.

Based on 0.00 analysts, Arch Biopartners Inc gets an average recommendation of "Strong Sell" according to Zacks. From those 0 analysts,.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..